Condition: Prenatal Exposure · Postnatal Exposure · Sponsor: Centre Hospitalier Universitaire de la Guadeloupe
In the context of environmental pollution of the French West Indies by chlordecone and questions about health consequences, monitoring at the peripubertal age of children born alive in the TIMOUN cohort is justified in several respects: - existence of an already established mother-child cohort whose live-born children will reach peripubertal ages during the period 2020-2022; - opportunity to verify hypotheses put forward on the basis of toxicological data acquired in laboratory animals and the hormonal characteristics of chlordecone (endocrine disruptor); - strong societal demand for such research to be carried out because of concerns about the sensitivity of children and adolescents to the effects of environmental xenobiotics, in particular on sexual development and the age of puberty; - recommendation of the Scientific Council Chlordecone Inserm - InVS; specific action of the National Plan Chlordecone IV.
This description comes directly from the study's public registry record.
Valérie HAMONY-SOTER · +590 590 93 46 77 · valerie.soter@chu-guadeloupe.fr
Eunice NUBRET · +590 590 93 46 86 · eunice.nubret@chu-guadeloupe.fr
Always discuss trial participation with your own doctor first.
| CHU of Guadeloupe | Pointe-à-Pitre, Guadeloupe, Guadeloupe | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06653660